Abstract: A method of operating a waste water treatment facility to prevent bulking in which growth of floc forming bacteria is promoted within a selector aeration tank by controlling absorption and bio-oxidation of biodegradable soluble chemical oxygen demand by the bacteria. Absorption is controlled through measurement of a percentage removal of biodegradable soluble chemical oxygen demand and bio-oxidation is controlled through measurement of temperature corrected specific oxygen uptake rate. Both the absorption and bio-oxidation levels are controlled by decreasing the degree to which wastewater influent flow bypasses the selector aeration tank in favor of the main aeration tank when either of absorption or bio-oxidation are below targeted ranges and increasing flow rate of recycle activated sludge from the clarifier to the main aeration tank while decreasing recycle activated sludge flow rate to the selector aeration tank when absorption and bio-oxidation are above such targeted ranges.

Abstract: The present invention provides for identification and use of small molecules to induce pluripotency in mammalian cells as well as other methods of inducing pluripotency.

Abstract: The present invention provides compounds of Formula (I) or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR120 G protein-coupled receptor modulators which may be used as medicaments.

Abstract: Disclosed are an MIMO antenna, a terminal and a method for improving MIMO antenna isolation. The MIMO antenna comprises at least two single antennas arranged on a printed circuit board (PCB); the single antenna comprising: an antenna support, a feeding grounding branch node used for shielding low-frequency coupling between the single antennas, a feeding point, a grounding point and an antenna radiation part, wherein the antenna support is arranged on the PCB, and the antenna radiation part is arranged on the antenna support; and the feeding grounding branch node is connected with the antenna radiation part via the feeding point and the grounding point.

Abstract: The present invention provides for identification and use of small molecules to induce pluripotency in mammalian cells as well as other methods of inducing pluripotency.

Abstract: The present invention provides for identification and use of small molecules to induce pluripotency in mammalian cells as well as other methods of inducing pluripotency.

Abstract: The present invention provides for identification and use of small molecules to induce pluripotency in mammalian cells as well as other methods of inducing pluripotency.

Abstract: The present invention provides compounds of Formula (I): (I) or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR120 G protein-coupled receptor modulators which may be used as medicaments.

Abstract: A computer-implemented method for analyzing free and open source software (FOSS) data related to FOSS components in source or binary codebase include receiving, by a computer, FOSS data. Each data record in the FOSS data includes identification of a FOSS component in source or binary codebase and data on one or more attributes of the FOSS component. The computer-implemented method further includes storing the FOSS data in a column-based database and querying the FOSS data stored in the database to extract information to put in a FOSS compliance, quality or security report or bill of materials (BoM) for the source or binary codebase.

Abstract: Disclosed are an MIMO antenna, a terminal and a method for improving MIMO antenna isolation. The MIMO antenna comprises at least two single antennas arranged on a printed circuit board (PCB); the single antenna comprising: an antenna support, a feeding grounding branch node used for shielding low-frequency coupling between the single antennas, a feeding point, a grounding point and an antenna radiation part, wherein the antenna support is arranged on the PCB, and the antenna radiation part is arranged on the antenna support; and the feeding grounding branch node is connected with the antenna radiation part via the feeding point and the grounding point.

Abstract: The present invention relates to a display device having a plurality of sub-pixels wherein at least one of the sub-pixels has at least one reflection area and at least two transmission areas, comprising: a first substrate; a first electrode layer disposed over the first substrate; a second substrate; a second electrode layer disposed over the second substrate; a liquid crystal layer interposed between the first substrate and the second substrate; and a protrusion unit disposed on the second substrate; wherein the protrusion unit is disposed correspondingly to the reflection area, and the reflection area is interposed between the transmission areas.

Abstract: Embodiments of the present invention provide methods, program products, and systems to increase efficiency in message oriented middleware. Embodiments of the present invention can, responsive to receiving from an application an open request for a queue alias of a queue manager, provide to the application target cache information which includes a target name and a change flag count associated with the queue alias. Embodiments of the present invention can, responsive to receiving a message from the application that includes respective target cache information including a target name and a change flag count, determine a target location, wherein if the change flag count of the received message matches a current change flag count of the queue alias, the determined target location is a target location associated with the received target name.

Abstract: The present invention provides compounds of Formula (I) or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR120 G protein-coupled receptor modulators which may be used as medicaments.

Abstract: The present invention provides compounds of Formula (I): (I) or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR120 G protein-coupled receptor modulators which may be used as medicaments.

Abstract: The invention relates to a method and a device for determining the cell activation of a target cell by an activator, said method having the following steps: provision of a probe measuring device with a probe sample arrangement having a measuring probe and a sample holder; loading of the probe sample arrangement with a target cell and with an activator assigned to the target cell, the measuring probe being loaded with the activator, and the sample holder being loaded with the target cell, or vice versa; relative mutual displacement of the measuring probe and the sample holder until contact is made between the target cell and the activator by means of a displacement apparatus of the probe measuring device; recording of measurement values, indicating binding between the target cell and the activator, for the measuring probe with the probe measuring device during the relative displacement of the measuring probe and the sample holder; and determination of a dimension for the cell activation of the target cell from

Abstract: Functional imaging for localization in biological tissue entails measuring a response in the tissue (240) to electromagnetic radiation. A catheter (200) for real-time monitoring of cardiac ablation is employed to distinguish a hemorrhage zone (232) from the sandwiching necrotic and healthy tissue, or to distinguish exogenous photoacoustic contrast agent from bordering native tissue. A pair of wavelengths is selected for differential absorption (244) of the radiation in, correspondingly, the hemorrhage zone or where the contrast agent exists, and relatively similar absorption elsewhere. Near infrared laser or LED light may be used photoacoustically to serially acquire (S310, S320) the two datasets to be compared, each representative of a time waveform. Alternatively, acquisition is for a pair of wavelength bands of microwave-induced thermoacoustic data.

Abstract: Compounds are provided which are phosphonate and phosphinate activators and thus are useful in treating diabetes and related diseases and have the structure is a heteroaryl ring; R4 is —(CH2)n—Z—(CH2)m—PO(OR7)(OR8), —(CH2)nZ—(CH2)m—PO(OR7)R9, —(CH2)n—Z—(CH2)m—OPO(OR7)R9, —(CH2)nZ—(CH2)m—OPO(R9)(R10), or —(CH2)nZ—(CH2)m—PO(R9)(R10); R5 and R6 are independently selected from H, alkyl and halogen; Y is R7(CH2)s or is absent; and X, n, Z, m, R4, R5, R6, R7, and s are as defined herein; or a pharmaceutically acceptable salt thereof. A method for treating diabetes and related diseases employing the above compounds is also provided.

Abstract: Methods of modulating the immune response using pharmaceutical compositions containing crystalline adjuvants are described. In various embodiments the crystalline adjuvants are selected from the group consisting of monosodium urate (MSU), xanthine, basic calcium phosphate (BCP), calcium pyrophosphate dihydrate (CPPD), hydroxyapatite, calcium oxalate, cholesterol, lipid liquid, other crystalline lipids, lithium heparin, talc, and starch.

Abstract: The weighted-average-based position (244) in the temporal domain is computed based on the sampling of shear wave displacement (226) along the propagation path. The weighting is, for example, by displacement observed at times (230) corresponding to sampling and represents the time of arrival of the shear wave at the shear-wave propagation path location being sampled. In some embodiments, the computed shear-wave times of arrival at respective locations are functionally related to known inter-location distances (250) to derive shear-wave group velocity. The derived velocity can serve as input into known algorithms for estimating shear elasticity of the medium, such as body tissue, for purposes of clinical diagnosis and therapy assessment.

Abstract: The present invention provides for identification and use of small molecules to induce pluripotency in mammalian cells as well as other methods of inducing pluripotency.